Good Distribution Practices for Life Science Manufacturers

2020 was the year of life science supply chain breakdowns, elevating the importance of good distribution practices (GDP). The inherent gaps in quality measures that rose to the surface during the COVID-19 pandemic are now being leveraged by manufacturers as lessons learned to pave a more resilient path forward. There is no going back to the old ways of doing business in the life sciences supply chain. Change is here to stay as witnessed by trends that have emerged. Those manufacturers that are able and willing to evolve their quality processes will have a competitive edge post-pandemic and beyond.